EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

First‐time application of droplet digital PCR for methylation testing of the 11p15.5 imprinting regions

Elia Schlaich, Wouter H G Hubens, Thomas Eggermann iD

Molecular Genetics & Genomic Medicine · 2023

DOI: 10.1002/mgg3.2264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2023. Verfasst von Elia Schlaich und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Human Genetics and Genome Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany. Hauptthemen laut MEDLINE: Beckwith-Wiedemann Syndrome, Silver-Russell Syndrome, Imprinting Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Beckwith‐Wiedemann syndrome and Silver‐Russel syndrome are two imprinting disorders caused by opposite molecular alterations in 11p15.5. With the current diagnostic tests, their molecular diagnosis is challenging due to molecular heterogeneity and mosaic occurrence of the most frequent alterations. As the determination of precise (epi)genotype of patients is relevant as the basis for a personalized treatment, different approaches are needed to increase the sensitivity of diagnostic testing of imprinting disorders.

Methods

We established methylation‐specific droplet digital PCR approaches (MS‐ddPCR) for the two imprinting centers in 11p15.5, and analyzed patients with paternal uniparental disomy of chromosome 11p15.5 (upd(11)pat) and other imprinting defects in the region. The results were compared to those from MS‐MLPA (multiplex ligation‐dependent probe amplification) and MS‐pyrosequencing.

Results

MS‐ddPCR confirmed the molecular alterations in all patients and the results matched well with MS‐MLPA. The results of MS‐pyrosequencing varied between different runs, whereas MS‐ddPCR results were reproducible.

Conclusion

We show for the first time that MS‐ddPCR is a reliable and easy applicable method for determination of MS‐associated changes in imprinting disorders. It is therefore an additional tool for multimethod diagnostics of imprinting disorders suitable to improve the diagnostic yield.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Beckwith-Wiedemann SyndromeSilver-Russell SyndromeImprinting DisordersHumansDNA MethylationGenomic ImprintingMultiplex Polymerase Chain Reaction

Stichwörter der Autor:innen

MS-MLPAMS-ddPCRMS-pyrosequencingimprinting disordersmosaicism

Autor:innen und Institutionen

  • Institute for Human Genetics and Genome Medicine, Medical Faculty, RWTH Aachen University, Aachen, Germany.
  • Institute for Stem Cell Biology, Medical Faculty, RWTH Aachen University, Aachen, Germany.
  • Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.

ORCID-Profile: Thomas Eggermann

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Schlaich, E., Hubens, W. H. G., & Eggermann, T. (2023). First‐time application of droplet digital PCR for methylation testing of the 11p15.5 imprinting regions. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2264

Vancouver

Schlaich E, Hubens WHG, Eggermann T. First‐time application of droplet digital PCR for methylation testing of the 11p15.5 imprinting regions. Molecular Genetics & Genomic Medicine. 2023. doi:10.1002/mgg3.2264

BibTeX
@article{Schlaich2023,
  author = {Schlaich, Elia and Hubens, Wouter H G and Eggermann, Thomas},
  title = {First‐time application of droplet digital PCR for methylation testing of the 11p15.5 imprinting regions},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2023},
  doi = {10.1002/mgg3.2264}
}
Kostenlos starten →